Johnson & Johnson’s COVID-19 vaccine.Photo: EMMANUEL CROSET/AFP via Getty Images
Johnson & Johnson’s COVID-19 vaccine has been approved for emergency use in the United States.
On Sunday, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to recommend the Johnson & Johnson vaccine to adults 18 years and older in the U.S., according to theWashington Post.
And on Saturday, the Food and Drug Administration (FDA) authorized the vaccine, according to astatementfrom the federal agency.
“After a thorough analysis of the data, the FDA’s scientists and physicians have determined that the vaccine meets the FDA’s expectations for safety and effectiveness appropriate for the authorization of a vaccine for emergency use,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. “With today’s authorization, we are adding another vaccine in our medical toolbox to fight this virus.”
Marks added, “At the same time, the American people can be assured of the FDA’s unwavering commitment to public health through our comprehensive and rigorous evaluation of the data submitted for vaccines to prevent COVID-19.”
The vaccine from Johnson & Johnson is the third approved to fight the ongoingCOVID-19 pandemic, following the authorization of the Moderna and Pfizer vaccine. It is the first that requires only one shot and the first that can be stored at refrigerator temperatures for months at a time.
JUSTIN TALLIS/AFP via Getty Images
Doses of the Johnson & Johnson vaccine are expected to begin shipping on Monday, according to theAssociated Press, which also reported that the company will be providing a “few million doses.”
Never miss a story — sign up forPEOPLE’s free daily newsletterto stay up-to-date on the best of what PEOPLE has to offer, from juicy celebrity news to compelling human interest stories.
Earlier this month, the FDA released areportconfirming that the vaccine is 66 percent effective at preventing moderate to severe COVID-19.
Though the overall effectiveness of the latest vaccine isn’t as strong as Pfizer and Moderna’s numbers, 95 percent and 94 percent, respectively, infectious disease experts said it is impossible to draw direct comparisons as Johnson & Johnson is a single dose and trials were conducted when there were more variants and infections,CNBCreported.
RELATED VIDEO: Couple Reunited After Longest Time Apart
After the announcement, President Joe Biden released astatementcalling the decision “exciting news for all Americans, and an encouraging development in our efforts to bring an end to the crisis.”
Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and a former acting director of the CDC, recently praised the FDA’s decision to have three vaccines made available for the public.
Over 70 million vaccine doses have been administered across the country as of Sunday afternoon, according toCDC data.
As information about thecoronavirus pandemicrapidly changes, PEOPLE is committed to providing the most recent data in our coverage. Some of the information in this story may have changed after publication. For the latest on COVID-19, readers are encouraged to use online resources from theCDC,WHOandlocal public health departments.PEOPLE has partnered with GoFundMeto raise money for the COVID-19 Relief Fund, a GoFundMe.org fundraiser to support everything from frontline responders to families in need, as well as organizations helping communities. For more information or to donate, clickhere.
source: people.com
